Percutaneous gastric embolization for obesity: A prospective mid-term outcomes study.

Autor:	Soledispa Suárez CI; Unidad de Cardiología Intervencionista, Departamento de Cardiología, Instituto de Salud Cardiovascular (Isac-Med), Guayaquil, Ecuador. Electronic address: marianotorre33@gmail.com., Alarcón Cedeño R; Unidad de Cardiología Intervencionista, Departamento de Cardiología, Instituto de Salud Cardiovascular (Isac-Med), Guayaquil, Ecuador; Unidad de Investigación Cardiovascular, Hospital Álvaro Cunqueiro. Área Sanitaria de Vigo, SERGAS, Vigo, Pontevedra, España; Grupo de Investigación Cardiovascular, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Pontevedra, España., de la Torre Fonseca LM; Unidad de Cuidados Intensivos, Hospital Docente Clínico Quirúrgico Comandante Manuel Fajardo, La Habana, Cuba; Universidad de Ciencias Médicas de la Habana (UCMH), La Habana, Cuba., Alberca Bonilla SS; Servicio de Medicina, Instituto de Salud Cardiovascular (Isac-Med), Guayaquil, Ecuador., Loor Cedeño F; Servicio de Medicina, Universidad Pontificia Católica de Río de Janeiro, Río de Janeiro, Brasil., Briones Fajardo ME; Dirección Financiera, Instituto de Salud Cardiovascular (Isac-Med), Guayaquil, Ecuador., Juan-Salvadores P; Unidad de Investigación Cardiovascular, Hospital Álvaro Cunqueiro. Área Sanitaria de Vigo, SERGAS, Vigo, Pontevedra, España; Grupo de Investigación Cardiovascular, Instituto de Investigación Sanitaria Galicia Sur (IIS Galicia Sur), SERGAS-UVIGO, Vigo, Pontevedra, España.
Jazyk:	English; Spanish; Castilian
Zdroj:	Medicina clinica [Med Clin (Barc)] 2024 Nov 26. Date of Electronic Publication: 2024 Nov 26.
DOI:	10.1016/j.medcli.2024.09.028
Abstrakt:	Introduction: Obesity represents one of the most pressing public health challenges that needs to be solved globally, with serious health implications. Despite primary prevention efforts the prevalence of obesity continues to increase. Percutaneous gastric embolisation (PGE) has emerged as a promising technique in the management of this disease. Material and Methods: Prospective longitudinal cohort study including 15 patients diagnosed with grade III obesity, admitted to the Haemodynamics Service of the Cardiovascular Health Institute during the year 2022. Results: The 86.7% of the PGEs were successful. Treated patients experienced significant weight loss when comparing baseline weight (101.2±23.0, SE=5.9) with weight at 6 months after the interventional procedure (91.5±19.8, SE=5.1) t(14)=5.3, P<.001, d=0.45, especially males (106.7±18.4, P=.01). No major vascular complications, gastric ulcer or ischaemia, or abdominal symptoms were documented in any of the patients included in the study. Only 6 patients (40%) presented with epigastralgia, 9 (60%) with nausea and 3 (20%) with vomiting. Conclusions: Percutaneous gastric embolisation is an effective and safe procedure to reduce BMI with a high success rate, well tolerated by obese patients, without major complications, whose results are maintained over time. (Copyright © 2024 Elsevier España, S.L.U. All rights reserved.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu